These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8478866)

  • 1. Sensitivity to change of rheumatoid arthritis clinical trial outcome measures.
    Anderson JJ; Chernoff MC
    J Rheumatol; 1993 Mar; 20(3):535-7. PubMed ID: 8478866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing a core set of disease activity measures for rheumatoid arthritis clinical trials.
    Felson DT
    J Rheumatol; 1993 Mar; 20(3):531-4. PubMed ID: 8478865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee.
    Goldsmith CH; Boers M; Bombardier C; Tugwell P
    J Rheumatol; 1993 Mar; 20(3):561-5. PubMed ID: 8478874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group.
    Tuttleman M; Pillemer SR; Tilley BC; Fowler SE; Buckley LM; Alarcón GS; Trentham DE; Neuner R; Clegg DO; Leisen JC; Heyse SP
    J Rheumatol; 1997 Oct; 24(10):1910-5. PubMed ID: 9330931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in clinical status measures in different ethnic/racial groups with early rheumatoid arthritis: implications for interpretation of clinical trial data.
    Yazici Y; Kautiainen H; Sokka T
    J Rheumatol; 2007 Feb; 34(2):311-5. PubMed ID: 17304656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group.
    Tilley BC; Pillemer SR; Heyse SP; Li S; Clegg DO; Alarcón GS
    Arthritis Rheum; 1999 Sep; 42(9):1879-88. PubMed ID: 10513802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of a health status measure to short-term clinical changes in arthritis.
    Anderson JJ; Firschein HE; Meenan RF
    Arthritis Rheum; 1989 Jul; 32(7):844-50. PubMed ID: 2665756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical measures in rheumatoid arthritis: which are most useful in assessing patients?
    Ward MM
    J Rheumatol; 1994 Jan; 21(1):17-27. PubMed ID: 7864914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials.
    Pincus T; Amara I; Segurado OG; Bergman M; Koch GG
    J Rheumatol; 2008 Feb; 35(2):201-5. PubMed ID: 18050378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis.
    Pincus T
    Bull NYU Hosp Jt Dis; 2008; 66(3):216-23. PubMed ID: 18937635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.
    American College of Rheumatology Committee to Reevaluate Improvement Criteria
    Arthritis Rheum; 2007 Mar; 57(2):193-202. PubMed ID: 17330293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials.
    Pham B; Cranney A; Boers M; Verhoeven AC; Wells G; Tugwell P
    J Rheumatol; 1999 Mar; 26(3):712-6. PubMed ID: 10090188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.
    Pincus T; Amara I; Koch GG
    Arthritis Rheum; 2005 Apr; 52(4):1031-6. PubMed ID: 15818698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rheumatoid arthritis clinical trial outcome measures: a simulation study.
    Anderson JJ; Bolognese JA; Felson DT
    Arthritis Rheum; 2003 Nov; 48(11):3031-8. PubMed ID: 14613263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodology issues in the evaluation of NSAID in inflammatory rheumatic diseases.
    Lequesne M
    J Rheumatol Suppl; 1990 Feb; 20():25-8. PubMed ID: 2182853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endpoints in rheumatoid arthritis.
    Tugwell P; Boers M; Baker P; Wells G; Snider J
    J Rheumatol Suppl; 1994 Oct; 42():2-8. PubMed ID: 7823314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents.
    Pincus T; Richardson B; Strand V; Bergman MJ
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-47-54. PubMed ID: 25365089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new disease activity index for rheumatoid arthritis: Mean Overall Index for Rheumatoid Arthritis (MOI-RA).
    Mäkinen H; Kautiainen H; Hannonen P; Sokka T
    J Rheumatol; 2008 Aug; 35(8):1522-7. PubMed ID: 18484699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.